VivoSim Labs, Inc.
VIVS
$0.45
-$0.05-10.87%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 53.85% | -7.14% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 53.85% | -7.14% | |||
| Cost of Revenue | -1.32% | 23.51% | |||
| Gross Profit | 2.60% | -24.47% | |||
| SG&A Expenses | 28.48% | -5.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.25% | 4.24% | |||
| Operating Income | -15.89% | -4.36% | |||
| Income Before Tax | -114.20% | -5.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -114.20% | -5.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -114.20% | -5.74% | |||
| EBIT | -15.89% | -4.36% | |||
| EBITDA | -16.53% | -4.74% | |||
| EPS Basic | -111.90% | -5.61% | |||
| Normalized Basic EPS | -115.35% | -5.70% | |||
| EPS Diluted | -111.90% | -5.61% | |||
| Normalized Diluted EPS | -115.35% | -5.70% | |||
| Average Basic Shares Outstanding | 1.09% | 0.12% | |||
| Average Diluted Shares Outstanding | 1.09% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||